Risør LM - Search Results

1

Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients.

Risør LM, Binderup T, Fosbøl MØ, Andersen KF, Loft A, Friborg J, Kjaer A. Risør LM, et al. Sci Rep. 2022 Nov 9;12(1):19126. doi: 10.1038/s41598-022-21175-7. Sci Rep. 2022. PMID: 36352036 Free PMC article.

2

FDG-PET/CT in the surveillance of head and neck cancer following radiotherapy.

Risør LM, Loft A, Berthelsen AK, Loft FC, Madsen AR, Vogelius IR, Kjær A, Friborg J. Risør LM, et al. Eur Arch Otorhinolaryngol. 2020 Feb;277(2):539-547. doi: 10.1007/s00405-019-05684-2. Epub 2019 Oct 23. Eur Arch Otorhinolaryngol. 2020. PMID: 31646385

3

Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with ¹⁸F-FDG PET/CT: A Single-Center Prospective Study.

Risør LM, Clausen MM, Ujmajuridze Z, Farhadi M, Andersen KF, Loft A, Friborg J, Kjaer A. Risør LM, et al. J Nucl Med. 2022 Aug;63(8):1169-1176. doi: 10.2967/jnumed.121.262866. Epub 2021 Dec 2. J Nucl Med. 2022. PMID: 34857658 Free PMC article. Clinical Trial.

4

Risk of breast cancer after false-positive test results in screening mammography.

von Euler-Chelpin M, Risør LM, Thorsted BL, Vejborg I. von Euler-Chelpin M, et al. Among authors: risor lm. J Natl Cancer Inst. 2012 May 2;104(9):682-9. doi: 10.1093/jnci/djs176. Epub 2012 Apr 5. J Natl Cancer Inst. 2012. PMID: 22491228

5

Hepatic erythropoietin response in cirrhosis.

Risør LM, Fenger M, Olsen NV, Møller S. Risør LM, et al. Scand J Clin Lab Invest. 2016;76(3):234-9. doi: 10.3109/00365513.2015.1137351. Epub 2016 Feb 29. Scand J Clin Lab Invest. 2016. PMID: 26924722

6

Hepatic erythropoietin response in cirrhosis. A contemporary review.

Risør LM, Fenger M, Olsen NV, Møller S. Risør LM, et al. Scand J Clin Lab Invest. 2016;76(3):183-9. doi: 10.3109/00365513.2016.1143563. Epub 2016 Feb 26. Scand J Clin Lab Invest. 2016. PMID: 26919118 Review.

7

Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction.

Risør LM, Bendtsen F, Møller S. Risør LM, et al. Hepatol Int. 2015 Jan;9(1):17-27. doi: 10.1007/s12072-014-9581-1. Epub 2014 Sep 27. Hepatol Int. 2015. PMID: 25788375 Review.

8

Author Correction: Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients.

Risør LM, Binderup T, Fosbøl MØ, Andersen KF, Loft A, Friborg J, Kjaer A. Risør LM, et al. Sci Rep. 2023 Jan 24;13(1):1346. doi: 10.1038/s41598-023-28618-9. Sci Rep. 2023. PMID: 36693915 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters